Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
about
Promiscuous drugs compared to selective drugs (promiscuity can be a virtue)Fatty acid ethyl ester, a non-oxidative ethanol metabolite, reverses the inhibitory effect of ibuprofen on platelet aggregationThe historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potentialActivation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infectionInduction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirinNSAIDs, Mitochondria and Calcium Signaling: Special Focus on Aspirin/SalicylatesInducible nitric oxide synthase mediates prostaglandin h2 synthase nitration and suppresses eicosanoid productionAntiplatelet drugs: mechanisms and risks of bleeding following cardiac operationsMolecular aspects of thrombosis and antithrombotic drugs.Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation.Inflammation in coronary artery disease: potential role for immunomodulatory therapy.Aspirin may promote mitochondrial biogenesis via the production of hydrogen peroxide and the induction of Sirtuin1/PGC-1α genes.Death in the substantia nigra: a motor tragedy.Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome.Evaluation of the pharmacokinetics and pharmacodynamics of ticagrelor co-administered with aspirin in healthy volunteersHomology modeling of human serum paraoxonase1 and its molecular interaction studies with aspirin and cefazolin.Calcium salicylate-mediated apoptosis in human HT-1080 fibrosarcoma cells.Anti-inflammatory, antinociceptive and antipyretic properties of the aqueous extract of Clematis brachiata leaf in male rats.MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study.Oxidative stress and inflammation in the endothelial dysfunction of obesity: a role for nuclear factor kappa B?Piroxicam and meloxicam ameliorate hepatic oxidative stress and protein carbonylation in Kupffer and sinusoidal endothelial cells promoted by ischemia-reperfusion injury.Effects of Nonsteroidal Anti-Inflammatory Drugs at the Molecular Level.
P2860
Q24799034-F72E449E-9111-4235-8E66-A8B407EC0C38Q28194474-9A8596C1-2981-479E-8100-8A38E8C9D524Q28195754-C575FD59-97EC-49BC-86E8-940AD0A20C32Q28472541-8F29EF78-2556-481A-810C-97F31BC8DFC4Q28570302-F8C1BA17-9768-4E50-A3ED-A2A3BF837241Q33664334-CCE65A76-6116-4F27-A82B-623D0E3B1ACFQ35070737-80392812-EEF8-4A9B-8754-8010042B5D21Q35902517-CD341A20-A8E9-416A-A178-BEBA2911D3AEQ36209119-38860D01-FA78-4648-9416-8E30705BE4EDQ36283698-DEFB1EB5-E554-4C94-8526-826F9F368425Q36314881-AA73745E-9E0D-4B31-9AF4-DD91B4F6BE60Q36747143-2E64391F-CD38-4C7C-BAAF-BF21C9BFAF14Q36847262-D6DA2EFA-8439-4B48-B638-FE496980F5A4Q37073714-8135BB89-72C0-49D4-B848-E8623B5A530AQ37259725-B3FB3A3D-6F92-4BDF-8037-625D7A9E5B33Q38450180-B9C9D923-A609-49DC-9F43-4DB00071F6E0Q40250938-0ADDEDA7-3580-4EB4-B464-148CC14D7953Q40353332-A9C74E13-BEA1-45AD-95B9-6A873535F568Q41099760-BA06DFE2-756B-4E9D-BCD6-C7937210F7C1Q42419915-0438BCE0-F472-4EF3-A9D3-7876D8D09A27Q45794055-3A2B1FBD-7798-4F48-A0D0-A84F04BB7005Q55531057-6E17D9A9-3128-4D7D-934B-E4DC62C14B86
P2860
Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
@ast
Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
@en
Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
@nl
type
label
Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
@ast
Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
@en
Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
@nl
prefLabel
Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
@ast
Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
@en
Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
@nl
P356
P1476
Aspirin and other cyclooxygenase inhibitors: new therapeutic insights
@en
P2093
Kenneth K Wu
P304
P356
10.1055/S-2003-40668
P407
P577
2003-05-01T00:00:00Z